Abstract
Objectives
Non-alcoholic fatty liver disease (NAFLD) is a common obesity-related comorbidity in childhood. In this study, we aimed to evaluate predictors of NAFLD by comparing clinical, endocrine and metabolic findings in obese children with and without hepatosteatosis.
Methods
Two hundred and eight obese children aged 6–18 years were included. The patients were divided into group 1 (patients with NAFLD, n=94) and group 2 (patients without NAFLD, n=114). Anthropometric measurements, pubertal stage, lipid profiles, fasting glucose and insulin, homeostatic model of assessment for insulin resistance (HOMA-IR), uric acid, total bilirubin, alanine aminotransferase (ALT), blood urea nitrogen, thyroid-stimulating hormone and free thyroxine parameters were compared retrospectively.
Results
The mean body weight, body mass index (BMI), height, tri-ponderal mass index (TMI), insulin, HOMA-IR, triglyceride, ALT and uric acid values were significantly higher, while high-density lipoprotein-cholesterol (HDL-C) values were significantly lower in group 1. The 70.7% of obese children with hepatosteatosis and 83.9% of those without hepatosteatosis were correctly estimated by parameters including age, gender, ALT, HDL-C, fasting insulin and uric acid values.
Conclusions
Since obesity-associated hepatosteatosis induces various long-term metabolic impacts in children, early detection is of critical importance. Age, gender, TMI, BMI, ALT, HDL-C, fasting insulin and uric acid values may help to predict the risk of hepatosteatosis. Besides, we assessed whether TMI compared to BMI does not have a better utility in estimating obesity-induced hepatosteatosis in children. This is the first study to show the association between TMI and hepatosteatosis in children.
-
Research funding: The authors received no financial support for the research, authorship and or publication of this article.
-
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Competing interests: No potential conflict of interest was reported by the authors.
-
Ethical approval: The study was approved by the Ethical Committee of the University of Health Sciences Zeynep Kamil Women and Children’s Diseases Training and Research Hospital.
References
1. World Health Organization. WHO obesity and overweight fact sheet; 2020. Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight [Accessed 1 Apr 2020].Search in Google Scholar
2. Vos, MB, Abrams, SH, Barlow, SE, Caprio, S, Daniels, SR, Kohli, R, et al.. NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr 2017;64:319. https://doi.org/10.1097/mpg.0000000000001482.Search in Google Scholar
3. Anderson, EL, Howe, LD, Jones, HE, Higgins, JP, Lawlor, DA, Fraser, A. The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis. PLoS One 2015;10:e0140908. https://doi.org/10.1371/journal.pone.0140908.Search in Google Scholar
4. Monteiro, R, Azevedo, I. Chronic inflammation in obesity and the metabolic syndrome. Mediat Inflamm 2010;2010:238–47. https://doi.org/10.1155/2010/289645.Search in Google Scholar
5. Chinetti, G, Fruchart, JC, Staels, B. Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applications. Int J Obes 2003;27:S41–5. https://doi.org/10.1038/sj.ijo.0802499.Search in Google Scholar
6. Papandreou, D, Rousso, I, Mavromichalis, I. Update on non-alcoholic fatty liver disease in children. Clin Nutr 2007;26:409–15. https://doi.org/10.1016/j.clnu.2007.02.002.Search in Google Scholar
7. Ratziu, V, Bellentani, S, Cortez-Pinto, H, Day, C, Marchesini, G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010;53:372–84. https://doi.org/10.1016/j.jhep.2010.04.008.Search in Google Scholar
8. Mencin, AA, Lavine, JE. Advances in pediatric nonalcoholic fatty liver disease. Pediatr Clin North Am 2011;58:1375–92. https://doi.org/10.1016/j.pcl.2011.09.005.Search in Google Scholar
9. Roberts, EA. Pediatric nonalcoholic fatty liver disease (NAFLD): a “growing” problem? J Hepatol 2007;46:1133–42. https://doi.org/10.1016/j.jhep.2007.03.003.Search in Google Scholar
10. Puri, K, Nobili, V, Melville, K, Corte, CD, Sartorelli, MR, Lopez, R, et al.. Serum bilirubin level is inversely associated with nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 2013;57:114–8. https://doi.org/10.1097/mpg.0b013e318291fefe.Search in Google Scholar
11. Lin, LY, Kuo, HK, Hwang, JJ, Lai, LP, Chiang, FT, Tseng, CD, et al.. Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents. Atherosclerosis 2009;203:563–8. https://doi.org/10.1016/j.atherosclerosis.2008.07.021.Search in Google Scholar
12. Sartorio, A, Del Col, A, Agosti, F, Mazzilli, G, Bellentani, S, Tiribelli, CL, et al.. Predictors of non-alcoholic fatty liver disease in obese children. Eur J Clin Nutr 2007;61:877–83. https://doi.org/10.1038/sj.ejcn.1602588.Search in Google Scholar
13. Marshall, WA, Tanner, JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291. https://doi.org/10.1136/adc.44.235.291.Search in Google Scholar
14. Deurenberg, P, Weststrate, JA, Seidell, JC. Body mass index as a measure of body fatness: age-and sex-specific prediction formulas. Br J Nutr 1991;65:105–14. https://doi.org/10.1079/bjn19910073.Search in Google Scholar
15. Günöz, H. Obesity. In: Neyzi, O, Ertuğrul, T, editors. Pediatrics, 3rd ed. Istanbul (Turkey): Nobel Press; 2002:201–6 pp.Search in Google Scholar
16. Kurtoğlu, S, Hatipoğlu, N, Mazıcıoğlu, M, Kendirici, M, Keskin, M, Kondolot, M. Insulin resistance in obese children and adolescents: HOMA-IR cut-off levels in the prepubertal and pubertal periods. J Clin Res Pediatr Endocrinol 2010;2:100.10.4274/jcrpe.v2i3.100Search in Google Scholar PubMed PubMed Central
17. Lee, SS, Park, SH. Radiologic evaluation of nonalcoholic fatty liver disease. World J Gastroenterol 2014;20:7392. https://doi.org/10.3748/wjg.v20.i23.7392.Search in Google Scholar
18. Artz, E, Haqq, A, Freemark, M. Hormonal and metabolic consequences of childhood obesity. Endocrinol Metab Clin N Am 2005;34:643. https://doi.org/10.1016/j.ecl.2005.04.004.Search in Google Scholar
19. Denzer, C, Thiere, D, Muche, R, Koenig, W, Mayer, H, Kratzer, W, et al.. Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance. J Clin Endocrinol Metab 2009;94:3872–81. https://doi.org/10.1210/jc.2009-1125.Search in Google Scholar
20. Schwimmer, JB, Deutsch, R, Kahen, T, Lavine, JE, Stanley, C, Behling, C. Prevalence of fatty liver in children and adolescents. Pediatrics 2006;118:1388–93. https://doi.org/10.1542/peds.2006-1212.Search in Google Scholar
21. Ozkol, M, Ersoy, B, Kasirga, E, Taneli, F, Bostanci, IE, Ozhan, B. Metabolic predictors for early identification of fatty liver using Doppler and B-mode ultrasonography in overweight and obese adolescents. Eur J Pediatr 2010;169:1345–52. https://doi.org/10.1007/s00431-010-1227-2.Search in Google Scholar
22. Peterson, CM, Su, H, Thomas, DM, Heo, M, Golnabi, AH, Pietrobelli, A, et al.. Tri-ponderal mass index vs body mass index in estimating body fat during adolescence. JAMA Pediatr 2017;171:629–36. https://doi.org/10.1001/jamapediatrics.2017.0460.Search in Google Scholar
23. Neves, FS, Alvim, RD, Zaniqueli, D, Pani, VO, Martins, CR, Peçanha, MA, et al.. Tri-ponderal mass index is useful for screening children and adolescents with insulin resistance. Rev Paul Pediatr 2020;38:e2019066. https://doi.org/10.1590/1984-0462/2020/38/2019066.Search in Google Scholar
24. Guzzaloni, G, Grugni, G, Minocci, A, Moro, D, Morabito, F. Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes 2000;24:772–6. https://doi.org/10.1038/sj.ijo.0801224.Search in Google Scholar
25. Chiarelli, F, Marcovecchio, ML. Insulin resistance and obesity in childhood. Eur J Endocrinol 2008;159:S67–74. https://doi.org/10.1530/eje-08-0245.Search in Google Scholar
26. Pirgon, Ö, Bilgin, H, Çekmez, F, Kurku, H, Dündar, BN. Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease. J Clin Res Pediatr Endocrinol 2013;5:33. https://doi.org/10.4274/jcrpe.825.Search in Google Scholar
27. Schwimmer, JB, Deutsch, R, Rauch, JB, Behling, C, Newbury, R, Lavine, JE. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 2003;143:500–5. https://doi.org/10.1067/s0022-3476(03)00325-1.Search in Google Scholar
28. Papandreou, D, Karavetian, M, Karabouta, Z, Andreou, E. Obese children with metabolic syndrome have 3 times higher risk to have nonalcoholic fatty liver disease compared with those without metabolic syndrome. Int J Endocrinol 2017;2017:2671692. https://doi.org/10.1155/2017/2671692.Search in Google Scholar
29. Bălănescu, A, Bălănescu, P, Comănici, V, Stan, I, Acs, B, Prisăcariu, L, et al.. Lipid profile pattern in pediatric overweight population with or without NAFLD in relation to IDF criteria for metabolic syndrome: a preliminary study. Rom J Inter Med 2018;56:47–54.10.1515/rjim-2017-0040Search in Google Scholar PubMed
30. El-Koofy, NM, Anwar, GM, El-Raziky, MS, El-Hennawy, AM, El-Mougy, FM, El-Karaksy, HM, et al.. The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children. Saudi J Gastroenterol 2012;18:44. https://doi.org/10.4103/1319-3767.91738.Search in Google Scholar
31. Pratt, DS, Kaplan, MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 2000;342:1266–71. https://doi.org/10.1056/nejm200004273421707.Search in Google Scholar
32. Schwimmer, JB, Newton, KP, Awai, HI, Choi, LJ, Garcia, MA, Ellis, LL, et al.. Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non‐alcoholic fatty liver disease. Aliment Pharmacol Ther 2013;38:1267–77. https://doi.org/10.1111/apt.12518.Search in Google Scholar
33. Radetti, G, Kleon, W, Stuefer, J, Pittschieler, K. Non‐alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging. Acta Paediatr 2006;95:833–7. https://doi.org/10.1080/08035250500449890.Search in Google Scholar
34. Ford, E, Li, C, Cook, S, Choi, H. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007;115:2526–32. https://doi.org/10.1161/circulationaha.106.657627.Search in Google Scholar
35. Fu, JF, Shi, HB, Liu, LR, Jiang, P, Liang, L, Wang, CL, et al.. Non-alcoholic fatty liver disease: an early mediator predicting metabolic syndrome in obese children? World J Gastroenterol 2011;17:735. https://doi.org/10.3748/wjg.v17.i6.735.Search in Google Scholar
36. Cardoso, AS, Gonzaga, NC, Medeiros, CC, de Carvalho, DF. Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents. J Pediatr (Rio J) 2013;89:412–8. https://doi.org/10.1016/j.jpedp.2012.12.011.Search in Google Scholar
37. Mutlu, RG, Ozsu, E, Cizmecioglu, FM, Hatun, S. Elevated TSH levels in obese children: what kind of problem is it?/Sisman cocuklarda hafif TSH yuksekligi: nasil bir sorun. Turk Arch Pediatr 2011:33–7. https://doi.org/10.4274/tpa.46.06.Search in Google Scholar
38. Kaltenbach, TM, Graeter, T, Oeztuerk, S, Holzner, D, Kratzer, W, Wabitsch, M, et al.. Thyroid dysfunction and hepatic steatosis in overweight children and adolescents. Pediatr Obes 2017;12:67–74. https://doi.org/10.1111/ijpo.12110.Search in Google Scholar
39. Torun, E, Özgen, İT, Gökçe, S, Aydın, S, Cesur, Y. Thyroid hormone levels in obese children and adolescents with non-alcoholic fatty liver disease. J Clin Res Pediatr Endocrinol 2014;6:34. https://doi.org/10.4274/jcrpe.1155.Search in Google Scholar
© 2021 Walter de Gruyter GmbH, Berlin/Boston
